NOTICE

Onegene Biotechnology is taking part in the European Association for the Study of the Liver (EASL) Annual Congress, and presenting a poster, "Effects of a Novel Tetra-Specific Drug (OGB21502) in the Obese Mice Model of Liver Disease". This cutting-edge research highlights the promising potential of our novel tetra-specific drug OGB21502 in addressing liver disease.